Angelalign Technology Inc
HKEX:6699
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
47.2
80
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Angelalign Technology Inc
Angelalign Technology Inc
Total Equity
Angelalign Technology Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Angelalign Technology Inc
HKEX:6699
|
Total Equity
¥3.3B
|
CAGR 3-Years
88%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Total Equity
¥1.9B
|
CAGR 3-Years
61%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Total Equity
¥12.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
22%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Total Equity
¥38.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Total Equity
¥3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Total Equity
¥18.9B
|
CAGR 3-Years
74%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Angelalign Technology Inc
Glance View
Angelalign Technology Inc., nestled in the ever-evolving healthcare landscape, has carved out its niche as a pivotal player in the orthodontics market, specifically through the design and production of clear aligners. Founded in 2003, this company has capitalized on growing aesthetic consciousness and technological advancements that converge in the orthodontic marketplace. Its core business thrives on innovation, leveraging digital orthodontic treatment solutions that streamline the traditionally cumbersome process of teeth alignment. By utilizing proprietary 3D printing and advanced imaging technology, Angelalign crafts personalized aligners that cater to the unique dental structure of each patient, enhancing comfort and effectiveness. These solutions are marketed to orthodontists and dental professionals, who then offer them to patients seeking alternatives to conventional braces, thus tapping into the escalating demand for oral health solutions that marry efficacy with cosmetic appeal. Angelalign's revenue stream primarily flows from the sales of its clear aligners, but the path to profitability goes beyond just product sales. The company has adeptly built an ecosystem around its core offerings, supplementing aligner sales with comprehensive support services to orthodontic practices. This includes digital platforms for patient management and treatment planning, ensuring a seamless integration with the routine operations of dental clinics. Furthermore, Angelalign invests meticulously in its R&D, continuously refining its technology and expanding its treatment capabilities, which fuels repeat business and consolidates its brand reputation. By embedding itself as a partner to dental professionals and focusing on delivering superior patient outcomes, Angelalign Technology Inc. not only seizes a significant market share but also positions itself as a beacon of orthodontic innovation within the broader healthcare technology sector.
See Also
What is Angelalign Technology Inc's Total Equity?
Total Equity
3.3B
CNY
Based on the financial report for Dec 31, 2023, Angelalign Technology Inc's Total Equity amounts to 3.3B CNY.
What is Angelalign Technology Inc's Total Equity growth rate?
Total Equity CAGR 5Y
82%
Over the last year, the Total Equity growth was -7%. The average annual Total Equity growth rates for Angelalign Technology Inc have been 88% over the past three years , 82% over the past five years .
You don't have any saved screeners yet
